LegoChem Biosciences, Inc. (LCB) is a research-based biotechnology company dedicated to the discovery, development, and commercialization of innovative medicines by leveraging our chemistry expertise to make conventional biologics more targeted and potent for the benefit of patients with diseases of highly unmet medical needs. We are advancing sustainable pipelines in therapeutic areas within antibiotics, anti-coagulants, oncology, antibody-drug conjugate (ADC), and protein-drug conjugate (PDC).
The order this company entered each market — oldest to newest
Korean biotech seeks breakthrough in ADC development
Korean biotech seeks breakthrough in ADC development
Sign up to see the full signal feed
How LegoChem Biosciences's international expansion compares to its competitors
LegoChem BiosciencesYouBars show relative size across the companies compared.
Columns5| Company | Markets | New markets | Momentum | Activity | Expansion score |
|---|---|---|---|---|---|
 LegoChem BiosciencesYou | 0 | 0 | 0% | 0 | 10 |
Not hiring right now
Sign up to track this company and get alerted the moment something changes.
No active campaigns
Sign up to track this company and get alerted the moment something changes.
Quantum computing is set to revolutionize drug development and precision medicine, offering superior computational power and efficiency. Yonsei University leads research with IBM's 127-qubit quantum computer.
KOSPI closed down 0.34% at 2556.61, awaiting US Big Tech earnings. Tariff uncertainties persist. Foreign and institutional investors sold, while individuals bought.
Korean biotech firms discuss strategies to compete with China in ADC development, focusing on overcoming resistance and differentiation at Samsung Seoul Hospital conference.
Unlock verified emails & direct dials
Free · No credit card needed
Quick answers about LegoChem Biosciences's business, markets, and growth signals.
Pubrio glocalizes business, people, and intent data from 50+ local sources into one global graph, giving AI and revenue teams full‑market visibility.
© 2026 Pubrio. All rights reserved.
